06:25 AM EDT, 07/01/2024 (MT Newswires) -- Alvotech ( ALVO ) on Monday reported preliminary Q2 revenue of $196 million to $201 million as a result of top-line clinical results and new product launches.
Shares of the generic drug company were up more than 3% in recent Monday premarket activity.
Price: 12.60, Change: +0.44, Percent Change: +3.62